Headlines
-
Is pharmacy slowing e-script rollout?
Friday | Nov 20 2020MEDICAL organisations are painting the pharmacy profession as the stumbling block to the rollout of digital health in Australia, because a small proportion of the profession is reluctant to embrace the new technology, Queensland pharmacist, Karalyn Huxhagen, believes.
-
HIMR to close medicines safety gaps
Friday | Nov 20 2020NEW funding models to support hospital-initiated medication reviews (HIMR) will help improve transition of care and boost medicines safety, the Society of Hospital Pharmacists of Australia (SHPA) believes.
-
Cancer cure claims raise TGA’s ire
Friday | Nov 20 2020A MELBOURNE-BASED company has been fined $39,960 by the Therapeutic Goods Administration (TGA) over alleged unlawful advertising, including claims that hydrogen peroxide could be used as a cancer treatment.
-
COVAX moves forward
Thursday | Nov 19 2020THE Therapeutic Goods Administration (TGA) is paving the way for the sponsors of a third COVID-19 candidate vaccine (COVAX) to seek provisional registration on the Australian Register of Therapeutic Goods (ARTG).
-
Pharmacy ideal for COVID vaccine
Thursday | Nov 19 2020AUSTRALIA'S community pharmacy network should be at the forefront of efforts to administer any successful COVID-19 vaccines to the public, Pharmacy Guild of Australia Executive Director, Suzanne Greenwood, believes.
-
FIP adds to COVID-19 guidance
Thursday | Nov 19 2020THE International Pharmaceutical Federation (FIP) has issued an addendum to its COVID-19 guidance following recent developments relating to vaccines and treatment for the pandemic virus.
-
NSW budgets for RTPM
Wednesday | Nov 18 2020FUNDING is set to be made available to deliver a real time prescription monitoring (RTPM) system in NSW.
-
Time to back pharmacy schools
Wednesday | Nov 18 2020COMMUNITY pharmacy owners are being urged to work with their local universities to encourage students to pursue careers in the profession.
-
SSRI script volumes on the rise
Wednesday | Nov 18 2020DATA from the Capital Chemist Group shows an 8.6% rise in prescription volumes for selective serotonin reuptake inhibitors (SSRIs) for the year to date, potentially showing the impact of the bushfire and COVID-19 crises.
-
Pharmacy’s SA COVAX role uncertain
Tuesday | Nov 17 2020SOUTH Australian Health Minister, Stephen Wade, believes it is too early to tell whether or not pharmacists will play a role in administering COVID-19 vaccines (COVAX) in the State.